Novus Light Home

Blog

Agilent in the UK

Agilent Technologies, Inc. opened a new state-of-the-art facility for spectroscopy research and development at the Harwell Science and Innovation Campus in Oxfordshire, UK.

A leader in molecular spectroscopy, the new Agilent site will be a major research and development hub for laser spectroscopy. It will also incorporate Agilent's Raman spectroscopy business, formerly known as Cobalt Light Systems (acquired by Agilent in 2017).

Agilent is focusing on investment in two main areas: research and development to enable customers to perform better science, and harmonizing existing product lines to ensure an optimal customer experience. The site will also accommodate the company's Laser Spectroscopy Center of Excellence (LSCE), focusing on research and development in the field of vibrational spectroscopy.

The Harwell Campus spans 710 acres south of Oxford, UK, and is well-known as a hub for science and innovation. Harwell is home to over 200 organizations (public, private, and academic), 6,000 people, and £2 billion of large-scale national science infrastructure. It is also where Agilent's proprietary Raman technologies were originally developed by Prof. Pavel Matousek, and his colleagues at the Science and Technology Facilities Council's Rutherford Appleton Laboratory, and where Cobalt Light Systems was first established.

Agilent UK has more than 480 employees across the UK in manufacturing, sales, and service. Agilent's two manufacturing sites in Shropshire manufacture liquid chromatography columns, silica and polymeric particles, and magnetic beads for the clinical and diagnostic industry; as well as instruments for gel permeation chromatography. This investment in the UK strengthens Agilent's role as a leader in molecular spectroscopy.

Labels: Agilent,vibrational spectroscopy,Raman,molecular,United Kingdom,medical,research

Back Back to News
 

Illuminating Products

Copyright © 2019 Novus Media Today Group, LLC. All rights reserved. Website design and build by MM Design.